Dr. Marjan M. Naeini

Employment

• Garvan Institute of Medical Research Computational biologist
  2021 - Present
• QIMR Berghofer Medical Research Institute Research Officer/PhD
  2018 - 2021

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (36)

• Convergent genomic and molecular features predict risk of metachronous metastasis in clear cell renal cell carcinoma
  Communications Medicine 2026 DOI: 10.1038/s43856-026-01436-6
  +Save
• A selective inhibitor of oncogenic JNK signalling perturbs metastatic outgrowth of triple-negative breast cancer through metabolic blockade
  2025 DOI: 10.1101/2025.04.16.649243
  +Save
• Convergent genomic and molecular features predict risk of metachronous metastasis in clear cell renal cell carcinoma
  2025 DOI: 10.1101/2025.01.07.630976
  +Save
• Spatial intra-tumour heterogeneity and treatment-induced genomic evolution in oesophageal adenocarcinoma: implications for prognosis and therapy
  Sandra Brosda, Lauren G. Aoude, Vanessa Bonazzi +29 more
  Genome Medicine 2024 DOI: 10.1186/s13073-024-01362-z
  +Save
• Multi-omic features of oesophageal adenocarcinoma in patients treated with preoperative neoadjuvant therapy
  Marjan Mojtabavi Naeini, Felicity Newell, Lauren G. Aoude +37 more
  Nature Communications 2023 DOI: 10.1038/s41467-023-38891-x
  +Save
• Data from Radiomics Biomarkers Correlate with CD8 Expression and Predict Immune Signatures in Melanoma Patients
  2023 DOI: 10.1158/1541-7786.c.6545076.v1
  +Save
• Data from Radiomics Biomarkers Correlate with CD8 Expression and Predict Immune Signatures in Melanoma Patients
  2023 DOI: 10.1158/1541-7786.c.6545076
  +Save
• Supplementary Figure 1 from Radiomics Biomarkers Correlate with CD8 Expression and Predict Immune Signatures in Melanoma Patients
  2023 DOI: 10.1158/1541-7786.22526397
  +Save
• Supplementary Figure 1 from Radiomics Biomarkers Correlate with CD8 Expression and Predict Immune Signatures in Melanoma Patients
  2023 DOI: 10.1158/1541-7786.22526397.v1
  +Save
• Supplementary Figure 2 from Radiomics Biomarkers Correlate with CD8 Expression and Predict Immune Signatures in Melanoma Patients
  2023 DOI: 10.1158/1541-7786.22526394
  +Save
• Supplementary Figure 2 from Radiomics Biomarkers Correlate with CD8 Expression and Predict Immune Signatures in Melanoma Patients
  2023 DOI: 10.1158/1541-7786.22526394.v1
  +Save
• Supplementary Figure 3 from Radiomics Biomarkers Correlate with CD8 Expression and Predict Immune Signatures in Melanoma Patients
  2023 DOI: 10.1158/1541-7786.22526391
  +Save
• Supplementary Figure 3 from Radiomics Biomarkers Correlate with CD8 Expression and Predict Immune Signatures in Melanoma Patients
  2023 DOI: 10.1158/1541-7786.22526391.v1
  +Save
• Supplementary Tables 1-4 from Radiomics Biomarkers Correlate with CD8 Expression and Predict Immune Signatures in Melanoma Patients
  2023 DOI: 10.1158/1541-7786.22526388
  +Save
• Supplementary Tables 1-4 from Radiomics Biomarkers Correlate with CD8 Expression and Predict Immune Signatures in Melanoma Patients
  2023 DOI: 10.1158/1541-7786.22526388.v1
  +Save
• Data from Pan-Cancer Analysis of Ligand–Receptor Cross-talk in the Tumor Microenvironment
  2023 DOI: 10.1158/0008-5472.c.6513046
  +Save
• Data from Pan-Cancer Analysis of Ligand–Receptor Cross-talk in the Tumor Microenvironment
  2023 DOI: 10.1158/0008-5472.c.6513046.v1
  +Save
• Supplementary Data from Pan-Cancer Analysis of Ligand–Receptor Cross-talk in the Tumor Microenvironment
  2023 DOI: 10.1158/0008-5472.22428508.v1
  +Save
• Supplementary Data from Pan-Cancer Analysis of Ligand–Receptor Cross-talk in the Tumor Microenvironment
  2023 DOI: 10.1158/0008-5472.22428508
  +Save
• Supplementary Data from Pan-Cancer Analysis of Ligand–Receptor Cross-talk in the Tumor Microenvironment
  2023 DOI: 10.1158/0008-5472.22428511.v1
  +Save